Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. scores highest on Anchor (49) and lowest on Nitro (16). Its PosiPenta is 34.15 out of 100, weaker than most similar companies.
On the Penta Grid this week, Rani Therapeutics Holdings, Inc. is Grid #694 of 837 in the Healthcare sector in United States, and Grid #3,357 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. | 34.15 | 26 | 44 | 16 | 36 | 49 |
| PDS Biotechnology Corporation | 37.17 | 0 | 56 | 70 | 8 | 51 |
| Pulmonx Corporation | 41.72 | 29 | 40 | 63 | 23 | 53 |
| Equillium, Inc. | 42.79 | 35 | 41 | 36 | 59 | 43 |
| Sera Prognostics, Inc. | 47.05 | 34 | 47 | 49 | 55 | 50 |
| NeOnc Technologies Holdings, Inc. | 43.24 | 0 | 43 | 22 | 94 | 57 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.27 |
| P/B ratio | 2.29 |
EEarnings
| Trailing EPS | ₹-14.21 |
| Forward EPS | ₹-18.00 |
NNitro
| Price | 60.67 |
| 52-week high | 366.55 |
| 52-week low | 58.06 |
| Fall from 52-week high | 83.4% |
TTorque
| Return on equity (ROE) | -172.15% |
| Debt-to-equity | 0.07 |
AAnchor
| Beta (price swings) | 0.71 |
| Market cap | ₹852 Cr |
| Insider holding | 4.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Rani Therapeutics Holdings, Inc.'s PosiPenta score?
Rani Therapeutics Holdings, Inc.'s PosiPenta is 34.15 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Rani Therapeutics Holdings, Inc. stand on the Penta Grid?
On the Penta Grid this week, Rani Therapeutics Holdings, Inc. is Grid #694 of 837 in the Healthcare sector in United States, and Grid #3,357 of 4,000 in United States.
Which PosiPenta pillar is strongest for Rani Therapeutics Holdings, Inc.?
Anchor (stability and dividends), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Rani Therapeutics Holdings, Inc.?
Nitro (momentum), with a score of 16 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.